Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of Biomarkers in Myocardial Fibrosis
Yuejia Ding, Yuan Wang, Wanqin Zhang, et al.
Aging and Disease (2020) Vol. 11, Iss. 5, pp. 1157-1157
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration
Drishtant Singh, Vikrant Rai, Devendra K. Agrawal
Cardiology and Cardiovascular Medicine (2023) Vol. 07, Iss. 01
Open Access | Times Cited: 176
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
Paolo Morfino, Alberto Aimo, Vincenzo Castiglione, et al.
Heart Failure Reviews (2022)
Open Access | Times Cited: 35
Sources, extractions and applications of bio-maker collagen–A review
Md. Rubel Alam, Md. Abdus Shahid, Shah Alimuzzaman, et al.
Biomedical Engineering Advances (2022) Vol. 4, pp. 100064-100064
Open Access | Times Cited: 35
Molecular Approaches and Echocardiographic Deformation Imaging in Detecting Myocardial Fibrosis
Andrea Sonaglioni, Gian Luigi Nicolosi, Elisabetta Rigamonti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10944-10944
Open Access | Times Cited: 30
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications
Alessandra Boschi, Luca Urso, Licia Uccelli, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine
Ali Fatehi Hassanabad, Anna N. Zarzycki, Paul W.M. Fedak
Cardiovascular Pathology (2024) Vol. 71, pp. 107635-107635
Open Access | Times Cited: 5
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
Pratima Nangia‐Makker, Victor Hogan, Vitaly Balan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102622-102622
Open Access | Times Cited: 19
Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation
Leon Blöbaum, Marco Witkowski, Max Wegner, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 176-176
Open Access | Times Cited: 11
FOXO3a Induces Myocardial Fibrosis by Upregulating Mitophagy
Dongsheng Lin, Hui Luo, Bo Dong, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2, pp. 56-56
Open Access | Times Cited: 4
Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study
Megan R. Rajah, Erna Marais, Gerald J. Maarman, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1143-1143
Open Access
Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients
Carina Ureche, Gianina Dodi, Alexandra Maria Covic, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 3003-3003
Open Access | Times Cited: 10
Prognostic value of morphological, biochemical, molecular markers of fibrosis in patients with hypertrophic cardiomyopathy
G. A. Burnasheva, R. P. Myasnikov, О. В. Куликова, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 22, Iss. 12, pp. 3839-3839
Open Access | Times Cited: 3
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
Noha M. El-Khodary, Asser I. Ghoneim, Ahmed A. El-tayaar, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 37, Iss. 5, pp. 955-964
Open Access | Times Cited: 14
Defining cardiac fibrosis complexity and regulation towards therapeutic development
Bethany Claridge, Auriane Drack, Alexander R. Pinto, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension
Krasimir Kostov, Alexander Blazhev
Bioengineering (2022) Vol. 9, Iss. 3, pp. 119-119
Open Access | Times Cited: 12
Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis
An Aldia Asrial, Reviono Reviono, Soetrisno Soetrisno, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e293-e293
Open Access | Times Cited: 2
Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation
Fouzi Alnour, Bo Eric Beuthner, Samy Hakroush, et al.
EuroIntervention (2024) Vol. 20, Iss. 12, pp. e760-e769
Closed Access | Times Cited: 2
Exploring in vivo and in vitro models for heart failure with biomarker insights: a review
Anil Kumar Prajapati, Gaurang Shah
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access | Times Cited: 2
Research Progress of Fibroblasts in Human Diseases
Xiaodong Li, Nana Li, Yujie Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1478-1478
Open Access | Times Cited: 2
Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis
Hagit Baris Feldman, Chofit Chai Gadot, David Zahler, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 18, pp. 1685-1692
Closed Access | Times Cited: 6
Ultrasonic Microbubble Cavitation Deliver Gal-3 shRNA to Inhibit Myocardial Fibrosis after Myocardial Infarction
Wenqu Li, Qiaofeng Jin, Li Zhang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 729-729
Open Access | Times Cited: 5
T2 and T2⁎ mapping and weighted imaging in cardiac MRI
Constantin‐Cristian Topriceanu, Iain Pierce, James Moon, et al.
Magnetic Resonance Imaging (2022) Vol. 93, pp. 15-32
Open Access | Times Cited: 8
Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
Sebastian Neuber, Miriam R. Ermer, Maximilian Y. Emmert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10480-10480
Open Access | Times Cited: 4
Qiangxinyin formula protects against isoproterenol-induced cardiac hypertrophy
Zhong-Yan Zhou, Jie Ma, Wai-Rong Zhao, et al.
Phytomedicine (2024) Vol. 130, pp. 155717-155717
Open Access | Times Cited: 1
Connection between сardiac fibrosis biomarkers and echocardiography parameters in patients with various forms of atrial fibrillation
А. И. Кочетков, I. Yu. Orlova, О. Д. Остроумова, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 6, pp. 170-179
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top